Found: 29
Select item for more details and to access through your institution.
Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study.
- Published in:
- 2012
- By:
- Publication type:
- journal article
In vitro generation of cytotoxic effectors activated by interleukin 2 (IL-2): comparison of autologous peripheral blood stem cells (PBSC) from adults and children.
- Published in:
- Bone Marrow Transplantation, 2001, v. 27, n. 8, p. 869, doi. 10.1038/sj.bmt.1702870
- By:
- Publication type:
- Article
Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma.
- Published in:
- Bone Marrow Transplantation, 2001, v. 27, n. 5, p. 471, doi. 10.1038/sj.bmt.1702806
- By:
- Publication type:
- Article
Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma.
- Published in:
- Bone Marrow Transplantation, 2000, v. 25, n. 9, p. 937, doi. 10.1038/sj.bmt.1702376
- By:
- Publication type:
- Article
Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution.
- Published in:
- Bone Marrow Transplantation, 1999, v. 23, n. 8, p. 789, doi. 10.1038/sj.bmt.1701737
- By:
- Publication type:
- Article
Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure.
- Published in:
- Bone Marrow Transplantation, 1998, v. 22, n. 10, p. 989, doi. 10.1038/sj.bmt.1701483
- By:
- Publication type:
- Article
Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors.
- Published in:
- Bone Marrow Transplantation, 1998, v. 22, n. 6, p. 535, doi. 10.1038/sj.bmt.1701395
- By:
- Publication type:
- Article
La distraction pendant les soins, pensée par les parents d’enfants pris en charge en oncologie.
- Published in:
- Psycho-Oncologie, 2022, v. 16, n. 4, p. 359, doi. 10.3166/pson-2022-0217
- By:
- Publication type:
- Article
Le sujet et le handicap : accompagnement neuropsychologique et psychologique à long terme d’enfants atteints de cancer.
- Published in:
- Psycho-Oncologie, 2020, v. 14, n. 3, p. 137, doi. 10.3166/pson-2020-0131
- By:
- Publication type:
- Article
Elevated Plasma Ferritin and Busulfan Pharmacodynamics During High-dose Chemotherapy Regimens in Children with Malignant Solid Tumors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2007, v. 82, n. 4, p. 402, doi. 10.1038/sj.clpt.6100168
- By:
- Publication type:
- Article
Thérapeutiques ciblées dans les tumeurs solides de l'enfant et de l'adolescent.
- Published in:
- Oncologie (Tech Science Press), 2016, v. 18, n. 11/12, p. 593, doi. 10.1007/s10269-016-2670-4
- By:
- Publication type:
- Article
Chimiothérapie à hautes doses et autogreffe en oncologie pédiatrique.
- Published in:
- Oncologie (Tech Science Press), 2007, v. 9, n. 12, p. 827, doi. 10.1007/s10269-007-0791-1
- By:
- Publication type:
- Article
A High-Dose Busulfan-Thiotepa Combination Followed by Autologous Bone Marrow Transplantation in Childhood Recurrent Ependymoma.
- Published in:
- Pediatric Neurosurgery, 1996, v. 25, n. 1, p. 7, doi. 10.1159/000121089
- By:
- Publication type:
- Article
P14.99 Clinical and biologic features predictive of survival after relapse of childhood medulloblastoma.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. iii91, doi. 10.1093/neuonc/noz126.334
- By:
- Publication type:
- Article
Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 8, p. 1083, doi. 10.1038/bmt.2015.118
- By:
- Publication type:
- Article
High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy.
- Published in:
- Bone Marrow Transplantation, 2005, v. 36, n. 11, p. 939, doi. 10.1038/sj.bmt.1705162
- By:
- Publication type:
- Article
Cost effectiveness of day 5 G-CSF (Lenograstim<sup>®</sup>) administration after PBSC transplantation: results of a SFGM-TC randomised trial.
- Published in:
- Bone Marrow Transplantation, 2005, v. 36, n. 6, p. 547, doi. 10.1038/sj.bmt.1705097
- By:
- Publication type:
- Article
In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa).
- Published in:
- Bone Marrow Transplantation, 2003, v. 32, n. 10, p. 979, doi. 10.1038/sj.bmt.1704275
- By:
- Publication type:
- Article
Neuropsychological outcome in long-term survivors of a childhood extracranial solid tumor who have undergone autologous bone marrow transplantation.
- Published in:
- Bone Marrow Transplantation, 2003, v. 31, n. 7, p. 599, doi. 10.1038/sj.bmt.1703882
- By:
- Publication type:
- Article
How do parents perceive high-dose chemotherapy and autologous stem cell transplantation for their children.
- Published in:
- Bone Marrow Transplantation, 2002, v. 30, n. 1, p. 35, doi. 10.1038/sj.bmt.1703587
- By:
- Publication type:
- Article
Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 1, p. 113, doi. 10.1007/s00280-007-0455-2
- By:
- Publication type:
- Article
Candida infections in children treated with conventional chemotherapy for solid tumors (transplant recipients excluded): The Institut Gustave Roussy Pediatrics Department experience.
- Published in:
- Pediatric Blood & Cancer, 2004, v. 42, n. 4, p. 332, doi. 10.1002/pbc.10452
- By:
- Publication type:
- Article
Diffuse intrinsic pontine gliomas (DIPG) at recurrence: is there a window to test new therapies in some patients?
- Published in:
- Journal of Neuro-Oncology, 2018, v. 137, n. 1, p. 111, doi. 10.1007/s11060-017-2702-7
- By:
- Publication type:
- Article
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations.
- Published in:
- British Journal of Cancer, 1999, v. 79, n. 5/6, p. 787, doi. 10.1038/sj.bjc.6690126
- By:
- Publication type:
- Article
p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma.
- Published in:
- 2010
- By:
- Publication type:
- journal article